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We compared the perioperative and oncological outcomes of laparoscopic radical cystectomy (LRC)
between elderly patients over 75 years old and younger patients. Fifty-three patients underwent LRC
between 2003 and 2014 at Tenriyorozu Hospital. Eighteen patients were classiﬁed as elderly (over 75) and
the other 35 patients were considered young. The median operating time (434 vs 465 min, p＝0.35),
estimated blood loss (534 vs 525 g, p＝0.74), time to recommencing food intake (7 vs 6 days, p＝1.00), and
hospital stay (35 vs 32 days, p＝0.81) were not signiﬁcantly different between the groups. Perioperative
pyelonephritis was signiﬁcantly more frequent in the elderly group (50% vs 20%, p＝0.02), while other
complications were not signiﬁcantly different between the two groups. The perioperative mortality rate was
0% in both groups. There were no signiﬁcant differences between the elderly and young groups with
respect to 2-year overall survival (74. 4% vs 91. 6%), cancer-speciﬁc survival (74. 4% vs 91. 6%), and
recurrence-free survival (70. 2% vs 81.8%). LRC is a safe and efﬁcient procedure for selected elderly
patients.
(Hinyokika Kiyo 61 : 479-485, 2015)




































にはカイ 2 乗検定，数値データの比較には Mann-





5 ポートで行った．ポート位置を Fig. 1 に示す．10
mm ポートは，回腸導管の場合には後のストーマ設置
場所となるように位置を調節した．リンパ節郭清は内
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Fig. 1. Port location.






Median age 77 (75-88) 64 (38-74)
Gender (male : female) 16 : 2 30 : 5 0.75
Median BMI 24.5 24.5 0.99
ASA-PS 0.32
1 6 (33％) 15 (43％)
2 11 (61％) 20 (57％)




cTis, a, 1 3 (17％) 11 (31％)
cT2 8 (44％) 12 (34％)
cT3, 4 7 (39％) 12 (34％)
Neoadjuvant chemotherapy
Indication
cTis, a, 1 1 (33％) 0 0.05
cT2 1 (13％) 9 (75％) ＜0.01*




％) 18 (51％) 0.38
MEC 1 (6％) 1 (3％)





Ileal conduit 15 (83％) 22 (63％)




Lymph node dissection 8 (44％) 29 (83％) ＜0.01*
Urethrectomy 4 (22％) 14 (40％) 0.20
* P＜0.05.







Median operative time (min)
Total 434 (243-608) 465 (273-831) 0.25
Laparoscopic 216.5 (136-321) 210 (108-464) 0.90









-356) 217 (53-591) 0.70
Blood loss (g) 534 (137-2,300) 525 (20-2,500) 0.74
Transfusion (n)
Auto 7 (39％) 14 (40％)
Allo 3 (17％) 3 (9％)
Oral intake (days) 7 (4-17) 6 (3-19) 1.00
Hospital stay
(days) 35 (19
-307) 32 (22-144) 0.81
外腸骨，閉鎖領域のリンパ節を腹腔鏡下で郭清した．




患者背景を Table 1 に示す．高齢者群が18例，対照
群が35例であった．高齢者群の年齢は中央値で77歳
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Table 3. Pathological outcomes
Elderly (over 75)
(N＝18) Younger (N＝35) P value
Tumor stage ＜0.01*
pT0 0 13 (37％)
pTis, a, 1 2 (11％) 13 (37％)
pT2 6 (33％) 4 (11％)
pT3, 4 10 (56％) 5 (14％)
Margin positive 0 1 (3％) 0.45
LN positive 0 2 (6％) 0.30
* P＜0.05.







Major complication (≧class III)
Pyelonephritis 1 (6％) 1 (3％) 0.63
Ileus 1 (6％) 1 (3％) 0.63
Ureteral stricture 2 (11％) 4 (11％) 0.97
Urethral stricture 0 1 (3％) 0.47
Urine leakage 1 (6％) 0 0.16
Lymphocele 0 1 (3％) 0.47
Peritonitis 0 1 (3％) 0.47
Intestinal anastomosis leakage 0 1 (3％) 0.47
Gastric hemorrhage 1 (6％) 0 0.16
Minor complication (≦class II)
Pyelonephritis 8 (44％) 6 (17％) 0.03*
Ileus 2 (11％) 8 (23％) 0.30
Delirium 3 (17％) 1 (3％) 0.07
Urine leakage 0 5 (14％) 0.09
Lymphocele 1 (6％) 0 0.16
SSI 1 (6％) 0 0.16
Other infection (CD colitis,
tonsillitis, pneumonia) 6 (33
％) 7 (20％) 0.29
* P＜0.05.








Total 7 (39％) 6 (17％) 0.08
Local recurrence 1 (6％) 1 (3％) 0.63
Lymph node 1 (6％) 1 (3％) 0.63
Lung 3 (17％) 2 (6％) 0.20
Liver 1 (6％) 1 (3％) 0.63
Brain 0 1 (3％) 0.47
Bone 0 1 (3％) 0.47
Kidney 0 1 (3％) 0.47
Ureter 2 (11％) 2 (6％) 0.48
Urethra 1 (6％) 0 0.16













2y OS 74.4％ 91.6％ 0.19
2y CSS 74.4％ 91.6％ 0.13
2y RFS 70.2％ 81.8％ 0.07
* P＜0.05.


























存率は高齢者群と対照群でそれぞれ OS が74.4％ vs
91. 6％（p＝ 0. 19），CSS が 74. 4％ vs 91. 6％（p＝
0.13），RFS が70.2％ vs 81.8％（p＝0.07）であった．
両群の各生存率のカプランマイヤー曲線を Fig. 2A∼C
に示す．いずれについても両群間で有意差を認めな
かった．背景因子による OS の単変量解析を Table 6
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Fig. 2. Kaplan-Meier plots of overall survival (A).
泌61,12,01-2B
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Fig. 2. Recurrence-free survival (C).
Table 6. Univariate analysis of prognostic factors
on overall survival
Number The 2y OS P value
Age 0.20







2 or 3 32 85.5％































0.018），出血量は減少し（400 vs 500 cc，p＝0.038），
周術期のイレウスの発生率（4.8％ vs 28％ p＝0.038），
感染症の発生率（9.5％ vs 40％，p＝0.019）も有意に
低く， 3 年の OS が同等であり（81％ vs 76％ p＝
0.746）高齢者に対し LRC が推奨されると報告して
いる11)．また Guillotreau らは70歳以上で LRC または
ロボット支援腹腔鏡下膀胱全摘除術（RARC）を行っ
た膀胱癌患者74例を70歳未満の72例と比較し，周術期























告は少ないが，Albisinni らによる LRC 503例の検討
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